Quimada, Aiza Mae .

HRN: 29-17-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CEFAZOLIN 1GM (VIAL)
06/20/2026
06/20/2026
IV
2 Grams
PTOR
OR Prophylaxis; STAT CS
Remove - Pending Acceptance
06/20/2026
CEFAZOLIN 1GM (VIAL)
06/20/2026
06/22/2026
IVT
1g
Q8 X 3 Doses
S/p Primary Lstcs W/ Iud
Remove - Pending Acceptance
06/21/2026
CEFUROXIME 500MG (TAB)
06/21/2026
06/28/2026
PO
500mg
BID
S/P PLSTCS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: